Surgery for cerebral cavernous malformations: a systematic review and meta-analysis
- PMID: 34191202
- DOI: 10.1007/s10143-021-01591-5
Surgery for cerebral cavernous malformations: a systematic review and meta-analysis
Abstract
Background: We sought to quantify the risks of neurosurgical excision of cerebral cavernous malformations (CCMs) in a systematic review of cohort studies.
Methods: We updated our previous systematic review by searching OVID Medline, OVID EMBASE, and the Cochrane Library from 1 January 2013 to 30 April 2019. The primary outcome was a composite of death attributed to CCM or surgery, non-fatal symptomatic intracerebral haemorrhage (ICH), or new or worsened persistent non-haemorrhagic focal neurological deficit (FND).
Results: We included 70 cohorts, 67 reporting surgery alone, and three compared surgery to conservative management. A total of 5,089 patients (median age 36 years, 52% female) underwent surgery (total follow-up 19,404 patient-years). The annual rate of the composite outcome was 4.2% (95% CI 2.9 to 5.7; 46 cohorts; I2 = 93%), which was higher in cohorts reporting exclusively brainstem CCM (6.0%, 95% CI 4.1-8.3; 25 cohorts, I2 = 92%) versus predominantly supratentorial CCM (2.4%, 95% CI 1.3-3.8, 21 cohorts, I2 = 86%, phet = 0.001). The annual rate of the composite outcome was higher in cohorts with > 95% presenting with ICH (6.1%, 95% CI 4.2-8.4; 23 cohorts, I2 = 93%) versus others (2.3%, 95% CI 1.2-3.7; 23 cohorts, I2 = 83%, phet = 0.001). The incidence of the composite outcome did not change over time in cohorts of exclusively brainstem CCM (p = 0.7) or predominantly supratentorial CCM (p = 0.5).
Conclusions: The risk of death, ICH, or FND after CCM excision is ~ 4%. This risk is higher for brainstem CCM and CCM that have caused ICH but has not changed over time.
Trial registration: This systematic review was registered (PROSPERO CRD42019131246).
Keywords: Cerebral cavernous malformations; Intracranial haemorrhage; Neurological deficit; Surgery.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
References
-
- Akers A, Al-Shahi Salman R, Awad I, Dahlem K, Flemming K, Hart B, Kim H, Jusue-Torres I, Kondziolka D, Lee C, Morrison L, Rigamonti D, Rebeiz T, Tournier-Lasserve E, Waggoner D, Whtiehead K (2017) Synopsis of guidelines for the clinical management of cerebral cavernous malformations: consensus recommendations based on systematic literature review by the angioma alliance scientific advisory board clinical experts panel. Neurosurgery 80:665–680 - DOI
-
- Al-Shahi R, Bhattacharya JJ, Currie DG, Papanastassiou V, Ritchie V, Roberts RC, Sellar RJ, Warlow CP (2003) Prospective, population-based detection of intracranial vascular malformations in adults: the Scottish Intracranial Vascular Malformation Study (SIVMS). Stroke 34:1163–1169. https://doi.org/10.1161/01.STR.0000069018.90456.C9 - DOI - PubMed
-
- Al-Shahi Salman R, Berg M, Morrison L, Awad I (2008) Hemorrhage from cavernous malformations of the brain: definition and reporting standards. Stroke 39:3222–3230. https://doi.org/10.1161/STROKEAHA.108.515544 - DOI - PubMed
-
- Al-Shahi Salman R, Kitchen N, Thomson J, Ganesan V, Mallucci C, Radatz M, Priority Setting Partnership Steering Group C (2016) Top ten research priorities for brain and spine cavernous malformations. Lancet Neurol 15:354–355. https://doi.org/10.1016/S1474-4422(16)00039-9 - DOI
-
- Flemming KD, Graff-Radford J, Aakre J, Kantarci K, Lanzino G, Brown RD, Mielke MM, Roberts RO, Kremers W, Knopman DS, Petersen RC, Jack CR (2017) Population-based prevalence of cerebral cavernous malformations in older adults: Mayo Clinic Study of Aging. JAMA Neurol 74:801–805. https://doi.org/10.1001/jamaneurol.2017.0439 - DOI - PubMed - PMC
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous